Bayer HealthCare / Press

Safety and Sustained Benefits of Adempas® From Bayer Confirmed by Results of Long-Term Studies

The two-year results of the open-label extension studies CHEST-2 and PATENT-2 confirm that the improvements in exercise capacity and WHO Functional Class (FC) as observed in the pivotal Phase III studies CHEST-1 and PATENT-1 were sustained. more      

In Focus

Healthcare News

Photos & Videos

  • Photos

    Photo galleries with topic-related images.

  • TV Footage

    In this section you can find videos for editorial coverage.

Bayer HealthCare Links

Annual report Integrated Annual Report of Bayer AG 2013
RSS Feed
RSS Feed

Copyright © Bayer HealthCare AG